NH Korindo Sekuritas Indonesia
Menu
  • OUR SERVICE
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
      • Special Notation
      • IPO
      • E-IPO
    • Equity
    • Fixed Income
    • Margin
    • Bonds
    • Wealth Management
      • Mutual Funds
    • Download Center
      • Download NAIK
      • Documents
    • Academy
      • Stock Dictionary
      • Stock Education
  • ABOUT US
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • Careers
    • FAQ
  • CONTACT
  • Register
  • EN
    • ID
  • ID
  • EN

Kalbe Farma Tbk (KLBF) Flat Growth Ahead

  • Author
  • Recent Posts
NHKSI Research Team
NHKSI Research Team
NHKSI Research Team
Latest posts by NHKSI Research Team (see all)
  • XA Update Report | Pakuwon Jati Tbk. (PWON) — Recurring Revenue Propels Growth - April 20, 2026
  • Daily Fixed Income | Pefindo Catat Pipeline Obligasi Korporasi Capai Rp66,28 Triliun - April 20, 2026
  • Daily Report | 20 Apr 2026 - April 20, 2026

Growth of 2.4% in Sales
KLBF’s sales grew by 2.4% from IDR4.89 trillion in 1Q17 into IDR5.01 trillion in 1Q18. The growth was boosted by the sales growth of 3.6%, 2.1%, 2.8%, and 0.5% respectively posted by the prescription drugs, the nutritional food, the distribution, and the consumer health.

Lowest Sales Growth by the Nutritional Food
Based on the Nielsen Retail data, the sales volume of dairy powder in Indonesia edged down 2.5% from 203 million tons in 2016 into 198 million tons in 2017. We estimate that the downtrend likely impacted on the nutritional food. Of note, the nutritional food posted the 1Q18 growth of 2.1% the last-5-year-lowest growth.

Download full report HERE.

Share This Article

Related Article


XA Update Report | Pakuwon Jati Tbk. (PWON) — Recurring Revenue Propels Growth

20 Apr 2026

Pakuwon Jati (PWON) reported a 7% YoY increase in revenue for FY25 to IDR 7.11 trillion with net profit margin improving to 35.4%.

XA Update Report | PT Samudera Indonesia Tbk. (SMDR) — In-line With Our Top-line Forecast, Bottom-line Pressured Lower Than Anticipated

17 Apr 2026

We maintain our BUY rating on SMDR with an upgraded TP of IDR 500 (Previously IDR 400) because of the geopolitical uncertainties primarily capitulated by the US-Iran-Israel conflict disrupting maritime traffic and causing rising shipping logistic fees.

XA Update Report | PT Dayamitra Telekomunikasi Tbk. (MTEL) – Stable Despite Slow Growth, Fiber Lends Support in FY25

15 Apr 2026

MTEL closed FY25 with revenue reaching IDR 9.53T, increased by 2.4% YoY (FY24: IDR 9.31T). On a quarterly basis, MTEL's revenue in 4Q25 increased by +16.1% QoQ and +9.8% YoY to IDR 2.65T (3Q25: IDR 2.28T | 4Q24: IDR 2.41T).

 

More Article

Analysis Report

20 Apr 2026

XA Update Report | Pakuwon Jati Tbk. (PWON) — R...

Pakuwon Jati (PWON) reported a 7% YoY increase in revenue for FY25 to IDR 7.11 trillion...

READ MORE

Fixed Income

20 Apr 2026

Daily Fixed Income | Pefindo Catat Pipeline Obl...

PT Pemeringkat Efek Indonesia (Pefindo) mencatat total mandat (pipeline) penerbitan obl...

READ MORE

Daily Report

20 Apr 2026

Daily Report | 20 Apr 2026

The JCI closed flat at +0.17% in the green at 7,634. The Indonesian market appears incr...

READ MORE

Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Certified By

Data yang ditampilkan di aplikasi PT NH Korindo Sekuritas Indonesia berasal dari BEI dan telah disetujui untuk ditampilkan.

PT NH Korindo Sekuritas Indonesia berizin dan diawasi oleh Otoritas Jasa Keuangan (OJK).


© Copyright 2026 NH Korindo Sekuritas. All rights reserved.